Staar Results 2024 Release Date. Staar surgical announces preliminary results for fourth quarter and fiscal 2023. Icl sales of $5 million.
Net sales up 19% for fourth quarter and 13% for fiscal 20231 icl sales up 22% for fourth quarter and 18% for fiscal 2023 provides fiscal 2024 sales outlook. First quarter 2024 financial results.
Eps Of $0.11 Beats By $0.05 | Revenue Of $77.36M (5.21% Y/Y) Beats By $1.41M.
Staa), a leading developer, manufacturer and marketer of the evo family of implantable collamer® lenses (evo.
Total Net Sales In Excess Of $77 Million.
Net sales were $77.4 million for the first quarter of 2024, up 5% compared to $73.5 million reported in the prior year quarter.
Net Sales Were $77.4 Million For The First Quarter Of 2024, Up 5% Compared To $73.5 Million Reported In The Prior Year Quarter.
Images References :
Eps Of $0.11 Beats By $0.05 | Revenue Of $77.36M (5.21% Y/Y) Beats By $1.41M.
You can analyze average scale scores and the percentage of students.
Jan 8, 2024 7:00Am Est.
Staa), a leading developer, manufacturer and marketer of the evo family of implantable collamer® lenses (evo.
You Can Use Test Results To Check The Performance Of A Group Over Time.